AMANDA PAGE: Open Payments
NPI 1972840940 · DUBLIN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 22 payments from 9 companies in 2025. Trend: 2023 $96 · 2024 $265 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $74 |
| Amgen Inc. | 4 | $62 |
| Novo Nordisk Inc | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Exact Sciences Corporation | 2 | $47 |
| ABBVIE INC. | 2 | $39 |
| Lilly USA, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: NURTEC ODT, Cologuard Collection Kit, OTEZLA, TRELEGY ELLIPTA, Ozempic, QULIPTA, AREXVY, MOUNJARO.
Industry payments across VA — which companies pay providers there.
